King Files 20 Levoxyl Patent Applications; Sales Up 65% to $27 Mil. In Q3

King has filed 20 patent applications for Levoxyl (levothyroxine) to extend exclusivity for the thyroid hormone product, the company said during an Oct. 29 earnings call

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet